You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Ethacrynic acid - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for ethacrynic acid and what is the scope of patent protection?

Ethacrynic acid is the generic ingredient in two branded drugs marketed by Bausch, Agnitio, Alvogen, Amneal Pharms Co, Chartwell Rx, Edenbridge Pharms, Hikma, Lupin Ltd, Par Pharm Inc, Sciegen Pharms Inc, and Upsher Smith Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for ethacrynic acid. Ten suppliers are listed for this compound.

Summary for ethacrynic acid

US Patents:	0
Tradenames:	2
Applicants:	11
NDAs:	11
Drug Master File Entries:	13
Finished Product Suppliers / Packagers:	10
Raw Ingredient (Bulk) Api Vendors:	82
Clinical Trials:	4
Patent Applications:	6,660
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for ethacrynic acid
What excipients (inactive ingredients) are in ethacrynic acid?	ethacrynic acid excipients list
DailyMed Link:	ethacrynic acid at DailyMed

See drug prices for ethacrynic acid

Recent Clinical Trials for ethacrynic acid

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Sintesi Research Srl	Phase 1
Aptuit Srl	Phase 1
Pari Pharma GmbH	Phase 1

See all ethacrynic acid clinical trials

Pharmacology for ethacrynic acid

Drug Class	Loop Diuretic
Physiological Effect	Increased Diuresis at Loop of Henle

Medical Subject Heading (MeSH) Categories for ethacrynic acid

Diuretics
Enzyme Inhibitors

US Patents and Regulatory Information for ethacrynic acid

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal Pharms Co	ETHACRYNIC ACID	ethacrynic acid	TABLET;ORAL	208805-001	May 8, 2018	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Alvogen	ETHACRYNIC ACID	ethacrynic acid	TABLET;ORAL	205709-001	Jul 24, 2018		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Par Pharm Inc	ETHACRYNIC ACID	ethacrynic acid	TABLET;ORAL	208501-001	Jul 21, 2017	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.